Mpox Outbreak, Drug Pricing Debates, and Obesity-Related Healthcare Costs

In today's episode, Dr. Chi-Ming Chow starts with an introduction to the episode's topics. He then addresses the current Mpox outbreak, discussing its status as a public health emergency, symptoms, and prevention measures. Dr. Chow explores the risks associated with Mpox, vaccination options, and compares it to the COVID-19 pandemic. The episode shifts to drug pricing, highlighting the recent Senate committee hearing with Novo Nordisk's CEO. Dr. Chow examines the economic impact of obesity-related healthcare costs and concludes with a debate on the responsibility for high drug prices, focusing on the roles of pharmaceutical companies and insurers.